APA

Behrens R. H., Cramer J. P., Jelinek T., Shaw H., von Sonnenburg F., Wilbraham D., Weinke T., Bell D. J., Asturias E., Pauwells H. L. E., Maxwell R., Paredes-Paredes M., Glenn G. M., Dewasthaly S., Stablein D. M., Jiang Z. & DuPont H. L. (20140422). Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. : The Lancet. Infectious diseases.

Chicago

Behrens Ronald H, Cramer Jakob P, Jelinek Tomas, Shaw Hilary, von Sonnenburg Frank, Wilbraham Darren, Weinke Thomas, Bell David J, Asturias Edwin, Pauwells Hermann L Enkerlin, Maxwell Roberto, Paredes-Paredes Mercedes, Glenn Gregory M, Dewasthaly Shailesh, Stablein Donald M, Jiang Zhi-Dong and DuPont Herbert L. 20140422. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. : The Lancet. Infectious diseases.

Harvard

Behrens R. H., Cramer J. P., Jelinek T., Shaw H., von Sonnenburg F., Wilbraham D., Weinke T., Bell D. J., Asturias E., Pauwells H. L. E., Maxwell R., Paredes-Paredes M., Glenn G. M., Dewasthaly S., Stablein D. M., Jiang Z. and DuPont H. L. (20140422). Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. : The Lancet. Infectious diseases.

MLA

Behrens Ronald H, Cramer Jakob P, Jelinek Tomas, Shaw Hilary, von Sonnenburg Frank, Wilbraham Darren, Weinke Thomas, Bell David J, Asturias Edwin, Pauwells Hermann L Enkerlin, Maxwell Roberto, Paredes-Paredes Mercedes, Glenn Gregory M, Dewasthaly Shailesh, Stablein Donald M, Jiang Zhi-Dong and DuPont Herbert L. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. : The Lancet. Infectious diseases. 20140422.